Invesaro

Stocks Comparison

Medifast vs Top Wealth: revenue, profit, margins and growth compared

Medifast brought in $385.8M of revenue in fiscal 2025, Top Wealth $9.1M in fiscal 2025. Revenue changed by -36.0% at Medifast and +92.3% at Top Wealth on the year before, so Top Wealth grew faster. Medifast kept -4.8% of its revenue as net profit, Top Wealth 34.9%.

Side by side, latest fiscal year

MEDTWG
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$385.8M$9.1M
Revenue growth-36.0%+92.3%
Net income-$18.7M$3.2M
Net margin-4.8%34.9%
Free cash flow$1.2Mn/a
Free cash flow margin0.3%n/a
Earnings per share (diluted)-$1.70$3.87
Cash$89.3M$2.4M
Debtn/an/a
Price to earningsn/an/a
Market value$136.1M$10.3M
Dividend yieldn/an/a
Rank by revenue in sector#69 of 93 · Consumer staples#88 of 93 · Consumer staples

Over the years

Revenue
MED FY2018: $501MMED FY2019: $713.7MMED FY2020: $934.8MMED FY2021: $1.5BMED FY2022: $1.6BMED FY2023: $1.1BMED FY2024: $602.5MMED FY2025: $385.8MTWG FY2021: $19.6KTWG FY2023: $8.5MTWG FY2023: $16.9MTWG FY2024: $4.7MTWG FY2025: $9.1MFY18FY19FY20FY21FY22FY23FY24FY25
MED $385.8MTWG $9.1M
Net income
MED FY2018: $55.8MMED FY2019: $77.9MMED FY2020: $102.9MMED FY2021: $164MMED FY2022: $143.6MMED FY2023: $99.4MMED FY2024: $2.1MMED FY2025: -$18.7MTWG FY2021: -$11KTWG FY2023: $1.9MTWG FY2023: $2.4MTWG FY2024: -$2MTWG FY2025: $3.2MFY18FY19FY20FY21FY22FY23FY24FY25
MED -$18.7MTWG $3.2M
Net margin
MED FY2018: 11.1%MED FY2019: 10.9%MED FY2020: 11.0%MED FY2021: 10.7%MED FY2022: 9.0%MED FY2023: 9.3%MED FY2024: 0.3%MED FY2025: -4.8%TWG FY2021: -56.1%TWG FY2023: 22.5%TWG FY2023: 14.4%TWG FY2024: -42.5%TWG FY2025: 34.9%FY18FY19FY20FY21FY22FY23FY24FY25
MED -4.8%TWG 34.9%
Revenue growth
MED FY2019: +42.4%MED FY2020: +31.0%MED FY2021: +63.2%MED FY2022: +4.8%MED FY2023: -32.9%MED FY2024: -43.8%MED FY2025: -36.0%TWG FY2023: +43,300.1%TWG FY2023: +99.0%TWG FY2024: -72.0%TWG FY2025: +92.3%FY19FY20FY21FY22FY23FY24FY25
MED -36.0%TWG +92.3%
Free cash flow
MED FY2018: $55.9MMED FY2019: $74.2MMED FY2020: $139.3MMED FY2021: $60.3MMED FY2022: $177.9MMED FY2023: $141.2MMED FY2024: $17MMED FY2025: $1.2MTWG FY2021: $792TWG FY2023: -$360.9KFY18FY19FY20FY21FY22FY23FY24FY25
MED $1.2MTWG -$360.9K

Fiscal years as each company reports them; the two may end in different months.

Questions about Medifast and Top Wealth

Which is bigger by revenue, Medifast or Top Wealth?

Medifast is bigger by revenue: $385.8M in fiscal 2025, against $9.1M for Top Wealth in fiscal 2025.

Which keeps more of its revenue as profit, Medifast or Top Wealth?

Medifast had a net margin of -4.8% in fiscal 2025; Top Wealth had 34.9% in fiscal 2025.

Which grew revenue faster, Medifast or Top Wealth?

In their latest fiscal years revenue changed by -36.0% at Medifast and +92.3% at Top Wealth.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies